ZOLPIDEM CIV |
ZOLPIDEM |
AMBIEN |
STILNOCT® |
AMBIEN® |
N,N,6-TRIMETHYL-2-(4-METHYLPHENYL)IMIDAZO(1,2-A)PYRIDINE-3-ACETAMIDE |
SL-80.0750-23N |
ZOLPIDEMUM |
SL 80.0750-23N |
pubchem.compound:5732 |
rxcui:39993 |
chembl:CHEMBL911 |
drugbank:00425 |
chemidplus:82626-48-0 |
Year of Approval | 1992 |
Drug Class | hypnotics and sedatives |
FDA Approval | approved |
Drug Class | Small Molecule |
Drug Indications | hypnotic |
Drug Categories | benzodiazepine hypnotics and sedatives |
Drug Categories | central nervous system depression |
Drug Categories | cytochrome p-450 cyp3a substrates |
Drug Categories | cytochrome p-450 substrates |
Drug Categories | gamma-aminobutyric acid-ergic agonist |
Drug Categories | miscellaneous anxiolytics sedatives and hypnotics |
Drug Categories | pyridines |
Drug Categories | sleep aids, pharmaceutical |
agonist (activating) |
allosteric modulator |
Details of the Assay for Interaction | Assay using recombinant GABA<sub>A</sub> channels with subunit composition; α2β1γ2. |
Specific Action of the Ligand | Positive |
Endogenous Drug? | False |
agonist (activating) |
allosteric modulator |
Trial Name | OX-22, zolpidem sublingual,Edluar, Sublinox |
Novel drug target | Established target |
Direct Interaction? | False |
agonist (activating) |
allosteric modulator |
potentiator |
Details of the Assay for Interaction | Assay using recombinant GABA<sub>A</sub> channels with subunit composition; α1β3γ2. |
Specific Action of the Ligand | Positive |
Endogenous Drug? | False |
ZOLPIDEM | DrugBank Drug Name |
82626-48-0 | CAS Number |
Adormix | Drug Brand |
Drug Type | small molecule |
Drug Groups | approved |
Drug Categories | benzodiazepine hypnotics and sedatives |
ZOLPIDEM | Primary Drug Name |
Drug Class | hypnotics and sedatives |
Year of Approval | 1992 |
Drug Indications | hypnotic |
Drug Class | Small Molecule |
FDA Approval | approved |
D0T1WN | TTD Drug ID |
ZOLPIDEM | GuideToPharmacology Ligand Name |
CHEMBL911 | ChEMBL Drug ID |